Summary
Overview
Work History
Education
Skills
Trainings and accomplishments
Research
Timeline
Generic

Satish Kumar Mahadevaiah Chandraiah, MD

Germering,BR

Summary

More than 12 years of experience in patient safety and pharmacovigilance, including leading a medical safety team. Experienced in leading patient safety strategy during clinical development through regulatory submissions. Skilled in leading responses to health authority questions and other key safety deliverables, such as DSUR, PSUR, RMP updates, and CDS updates. Proficient in safety signal management and presenting analysis to cross-functional teams and benefit-risk governance boards.

Overview

16
16
years of professional experience

Work History

Global Patient Safety (GPS) Risk Management Leader

Morphosys AG
03.2022 - Current

Domain: Hematology, Oncology, Immunology

  • Leading GPS Risk Management Team with safety physicians and safety scientists, setting clear objectives and managing skills required to meet project deliverables
  • Manage project teams effectively including resource constraints from attrition/ poor performances by team restructuring, outsourcing some activities, streamlining the processes
  • Ensure effective collaborations with cross functional teams and co-development partners as the leader or member of benefit risk governance committees (e.g., SMT, benefit risk governance board)
  • Represent medical safety in internal (e.g., protocol review committee)/ external committees (e.g., DMC, study steering committee) and audits/inspections as required
  • Reviewing/ contributing to the program level documents (e.g., periodic aggregate reports, clinical study reports, protocols/ ICFs, IB, CCSI updates)
  • Leading safety in health authority meetings including ISS safety strategy meeting with USFDA, pre-submission meetings with US FDA, EMA and PMDA consultations on Japanese specific trial
  • Supported due diligence and divestment activities
  • Supported safety operations team on the migration and consolidation of ARGUS safety database and literature review from multiple vendors to one vendor
  • Contribute to further development of GPS through knowledge sharing sessions and authoring/ reviewing process documents

Global program safety lead (GPSL)

Novartis healthcare Pvt Ltd
04.2019 - 02.2022

Domain: Hematology/ Oncology

  • Owns the safety strategy for assigned product and leads the production of the medical safety deliverables (e.g., DSUR, PSUR, RMP)
  • As a core member of global program team (cross-functional team), providing strategic inputs to the clinical development program
  • Core team member for new indication submission/ submission post-authorization commitments to various health authorities
  • Chair of the cross-functional SMT and joint SMT (with license partner)
  • Responsible for overall signal detection, monitoring, evaluation, interpretation and appropriate management of safety information, based on information from various sources (e.g., pre-clinical, clinical trial data post-marketing, literature)
  • Responsible for safety management throughout the Life Cycle of the medicinal product
  • Responsible for safety strategy of reference safety information in IB, CDS/ local labels
  • Leading the preparation of the safety strategy for health authority responses and strategy, in collaboration with other project team members
  • Preparing safety strategy and safety data for internal safety governance boards and health authority Meetings, as required
  • Providing expert medical input to trial and Data Monitoring Committee (DMC)
  • Medical review of SUSAR and Investigator notifications (IND-ICSR) and approval of sponsor causality.
  • Providing support as needed for audits and regulatory authority inspections
  • Leading a team of safety physicians as an operational manager

Senior Medical safety lead

Novartis healthcare Pvt Ltd
04.2017 - 03.2019

Domain: Hematology/ Oncology

  • Monitoring the clinical safety of assigned products including activities such as literature review, evaluation of single cases or signal detection, and responding to safety-related questions as appropriate
  • Performing medical assessment and related activities for ICSRs including collecting additional follow-up information as necessary.
  • Providing guidance as appropriate to clinical safety operations for the coding and causality/ expectedness assessment of adverse event reports
  • Providing inputs into responses to inquiries from regulatory authorities or healthcare professionals on safety issues
  • Responsible for aggregate regulatory reports such as PSURs
  • Development of RMP in collaboration with other line functions, providing safety inputs to CDS development and updates
  • Providing safety inputs for clinical and regulatory deliverables including protocols/ ICFs, clinical study reports, IB, submission documents
  • May deputize global program safety lead if required

Pharmacovigilance leader

Novartis healthcare Pvt Ltd
09.2015 - 03.2017

Domain: Hematology/ Oncology

  • Performing medical assessment and related activities for ICSRs including collecting additional follow-up information as necessary, medical evaluation of quality defects, preparation of investigator notifications
  • Providing guidance as appropriate to safety operations for the coding and causality/ expectedness assessment of adverse event reports
  • Providing input to the inquiries from regulatory authorities and healthcare professionals on safety issues
  • Providing inputs to aggregate safety regulatory reports, RMP and SPP
  • Perform signal detection, monitoring and evaluation based on single cases, aggregate data and signal detection tools
  • Member of clinical trial team as a trial safety lead and responsible for providing inputs to the protocol, ongoing safety review of the trial data, review of CSR and contribution to study steering committees/data monitoring committee meetings

Pharmacovigilance Expert

Novartis healthcare Pvt Ltd
12.2013 - 09.2015

Domain: Hematology/ Oncology

  • ICSR medical review including appropriately requesting follow up information for proper medical assessment
  • Providing guidance as appropriate to safety operations for the coding and causality/ expectedness assessment of adverse event reports
  • Contribute to sections of PSURs including analytical inputs for identified, potential risks and new safety signals discussed in PSUR
  • Perform literature review for PSUR inclusion
  • Provide support for preparation of responses to queries from regulatory authorities and health care professionals
  • Assist in preparation of product guidance documents if required for assigned products
  • Contribution to the RMP updates, DSUR and annual IB updates as required

Pharmacovigilance physician

Accenture life sciences
03.2012 - 12.2013

Domain: Immunology, anti-infectives

  • Medical review of ICSRs (solicited and unsolicited) in the areas of immunology, virology and other anti-infectives
  • Provide medical evaluation for the cases including medical assessment

Clinical pharmacologist/principal investigator

Ecron Acunova
06.2010 - 03.2012

Domain: Bioavailability/ Bioequivalence studies

  • Review of study protocols and clinical study documents (informed consent document, CRF, CSR)
  • Identifying eligible subjects for the study, based on clinical examination and laboratory investigations
  • Appropriate management of adverse events
  • Monitoring and reporting AE/SAEs as per regulatory timelines

Assistant professor of Pharmacology

Manipal University
06.2009 - 06.2010
  • Teaching clinical pharmacology to medical and dental students
  • Involved in basic and pre-clinical research

Education

M D - Pharmacology

Kasturba Medical College
01-2009

M.B.B.S. (Medical Graduation) - Medicine

Sri Siddhartha Medical College
Tumkur, India
01-2005

Skills

  • Medical safety leadership, including leading program safety strategy and safety teams
  • Product safety: Leading cross-functional team discussions and the lead safety physician in global program team
  • Aggregate assessment of safety topics including signal evaluation
  • Working effectively in global and cross-cultural teams
  • Extensive medical knowledge
  • In-depth knowledge of relevant regulatory guidelines
  • Good interpersonal, communication and presentation skills

Trainings and accomplishments

  • Accelerated Leadership Program, 2023 (Morphosys Sponsored)
  • Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation, CSDD, Tufts University, USA, 2020 (Novartis sponsored)
  • Leadership trainings: M1 Leading from the frontline, Excellence in Technical Leadership (ELITE) Program (Novartis sponsored)
  • Global exposure program for high performing, two months, Novartis East Hanover, Basel offices, 2015
  • Vision Award, 2015, Novartis
  • Oncology Clinical Trial Training, Catalyst Clinical Services, 2012
  • Post Graduate Diploma in Business Administration, Symbiosis Center, 2011

Research

  • Involved in basic & pre-clinical research at Kasturba Medical College, Manipal., 2006, 2009
  • Published pre-clinical research work in various national and international publications.

Timeline

Global Patient Safety (GPS) Risk Management Leader

Morphosys AG
03.2022 - Current

Global program safety lead (GPSL)

Novartis healthcare Pvt Ltd
04.2019 - 02.2022

Senior Medical safety lead

Novartis healthcare Pvt Ltd
04.2017 - 03.2019

Pharmacovigilance leader

Novartis healthcare Pvt Ltd
09.2015 - 03.2017

Pharmacovigilance Expert

Novartis healthcare Pvt Ltd
12.2013 - 09.2015

Pharmacovigilance physician

Accenture life sciences
03.2012 - 12.2013

Clinical pharmacologist/principal investigator

Ecron Acunova
06.2010 - 03.2012

Assistant professor of Pharmacology

Manipal University
06.2009 - 06.2010

M D - Pharmacology

Kasturba Medical College

M.B.B.S. (Medical Graduation) - Medicine

Sri Siddhartha Medical College
Satish Kumar Mahadevaiah Chandraiah, MD